This Week in CBD: August 24, 2018
Officials in Alabama announced this week that they will be cracking down on CBD sales in the state.
While two Alabama laws—Carly’s Law and Leni’s Law—define specific conditions under which CBD use is legal in the state, these laws don’t offer protections for people who do not meet those conditions.
According to Tim Glover, director of the Lauderdale County Drug Task Force,
“CBD oil is on the list of controlled substances, which makes it illegal in the state of Alabama…We’re hearing people say it’s legal, no one is getting hurt, it’s a good way to make money. It is illegal, and it’s a good way for these people to go to jail.”
In Texas, a Dallas-area man’s family says that he failed a drug test after using hemp-based CBD products. Because of the positive test result, the man’s doctors refused to perform a liver transplant due to “noncompliance.”
The man’s daughter, Monica Garcia, told Ministry of Hemp that her father used CBD to manage pain, and she was concerned about the effects of prescription painkillers on her father’s liver, saying, “What you prescribe him will kill him sooner!”
The hemp registry has “exploded” this year in Vermont, according to a report from NPR. In the four years since Vermonters have been allowed to grow hemp, the number of licensed growers has expanded to 400, with almost 3,000 acres currently devoted to the crop. And a lot of that hemp is earmarked for CBD products.
Readers of Medford, Oregon’s Mail Tribune were surprised to learn that there’s cannabis growing on the town’s Main Street. The 30-acre site is growing a a low-THC hemp variety.
A new report predicts that the CBD industry in the US will exceed $500 million this year, and will reach sales of about $2 billion by 2022.
Part of the predicted gains will be the result of GW Pharmaceuticals’ newly FDA-approved Epidiolex. According to New Frontier Data, this medication will account for about one-third of the total CBD market by 2022.
Medical cannabis company Revive Therapeutics has submitted an application to the FDA to try to obtain orphan drug designation for CBD as a treatment for hepatic ischemia and reperfusion injury (“IRI”) during liver transplantation.
This condition is one of the leading causes of liver dysfunction after transplantation. Revive Therapeutics believe that they may be able to harness the immunosuppressive and anti-inflammatory protective effects of CBD to avoid or reduce liver transplant complications.
This week, Rolling Stone reported on a new bill that would allow federal employees to use medical marijuana. Currently, even in states where medical marijuana is legal, government employees can lose their jobs over it. That’s because the DEA maintains that medical marijuana remains illegal at the federal level.
The Fairness in Federal Drug Testing Under State Laws Act would protect workers like Paul, the former Marine profiled in the article. He began using medical marijuana as an alternative to the pharmaceutical cocktail he was prescribed after losing his legs in Afghanistan.
While it would be legal for him to continue using the prescribed OxyContin, Ambien, Methadone, and Seroquel, Paul told Rolling Stone that,
“For me, getting blown up again, I’d rather do that than have to go through the detox of getting off those opioids.”
But by using medical marijuana, he risks losing his federal job.
CBD Deals and Promos
It’s a good time to order from Charlotte’s Web (CW Hemp). Ground shipping within the US will be FREE through Saturday, Aug. 25, 2018 at 11:59 p.m. MST.
Looking for a CBD product for your furry friends? For a limited time, Pure Hemp Botanicals is offering 20% off all pet products.